NEW BRUNSWICK, N.J.,
May 17, 2016 /PRNewswire/ -- Johnson
& Johnson (NYSE: JNJ) today announced a collaboration between
Johnson & Johnson Services, Inc. and a subsidiary of HP Inc.
The collaboration is focused on using 3D printing technologies to
create better health care outcomes at reduced costs. Working
together, the companies plan to combine their scientific, clinical,
material science and technological expertise, and deep insights to
develop products and solutions which can be manufactured quickly
and customized to the needs of an individual patient or
consumer.
In the near-term, the collaboration will focus on
personalization of instrumentation and software for
patient-specific healthcare devices. It is anticipated that
3D printing technology will lead to innovation in areas such as
orthopaedics, eye health and consumer products, among
others.
"The intersection of technology and health care is spurring
innovation that will have a profound impact on patients and
consumers all over the world," said Sandra
Peterson, Group Worldwide Chairman, Johnson &
Johnson. "Combined with advances in data mining and software,
3D printing could enable distributed manufacturing models and
patient-specific products, therapies and solutions that deliver
better outcomes, better economics and improved global
accessibility. This collaboration with HP Inc. exemplifies
our commitment to harnessing new technology to improve outcomes and
reduce costs across the health continuum."
"Advances in 3D printing technology have the potential to break
historical paradigms of health care delivery in ways that are not
feasible in traditional manufacturing processes," said Stephen Nigro, president of HP's 3D printing
business. "Together with Johnson & Johnson we have the
potential to create opportunities and innovations in health care to
improve patients' lives that neither company could develop
alone."
The collaboration announced today has already begun, with teams
of experts from both organizations working together.
About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites the
people of Johnson & Johnson. We embrace research and science -
bringing innovative ideas, products and services to advance the
health and well-being of people. Our approximately 127,500
employees at more than 250 Johnson & Johnson operating
companies work with partners in health care to touch the lives of
over a billion people every day, throughout the world.
Cautions Concerning Forward-Looking Statements
This press release contains "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995
related to a new collaboration and product development. The reader
is cautioned not to rely on these forward-looking statements. These
statements are based on current expectations of future events. If
underlying assumptions prove inaccurate or known or unknown risks
or uncertainties materialize, actual results could vary materially
from the expectations and projections of Johnson & Johnson
Services Inc. and/or Johnson & Johnson. Risks and uncertainties
include, but are not limited to: the potential that the expected
benefits and opportunities related to the collaboration may not be
realized or may take longer to realize than expected; challenges
inherent in new product development, including the uncertainty of
success and obtaining regulatory approvals; competition, including
technological advances, new products and patents attained by
competitors; uncertainty of commercial success for new products;
the ability of the company to successfully execute strategic plans;
impact of business combinations and divestitures; challenges to
patents; changes in behavior and spending patterns or financial
distress of purchasers of health care products and services; and
global health care reforms and trends toward health care cost
containment. A further list and description of these risks,
uncertainties and other factors can be found in Johnson &
Johnson's Annual Report on Form 10-K for the fiscal year ended
January 3, 2016, including in Exhibit
99 thereto, and the company's subsequent filings with the
Securities and Exchange Commission. Copies of these filings are
available online at www.sec.gov, www.jnj.com or on request from
Johnson & Johnson. Neither Johnson & Johnson Services Inc.
nor Johnson & Johnson undertake to update any forward-looking
statement as a result of new information or future events or
developments.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/johnson--johnson-announces-collaboration-with-hp-inc-subsidiary-to-create-personalized-health-care-solutions-with-3d-printing-technologies-300269925.html
SOURCE Johnson & Johnson